Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Adroit Financial Services Private Limited, Dilip Davda, Swastika Investmart Ltd and Ventura Securities Limited have given "Apply" recommendation to Kronox Lab Sciences IPO. Capital Market has "Neutral" view about the IPO. Asit C. Mehta Investment Intermediates Ltd, Axis Capital, JM Financial Institutional Securities and SMC Global have "Not Rated" the IPO.
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 4 | 0 | 1 | 0 | 4 |
| % | 44.44 | 0.00 | 11.11 | 0.00 | 44.44 |
| Reviewer | Recommendation | Past Reviews |
|---|---|---|
Adroit Financial Services Private Limited |
Apply |  |
| Asit C. Mehta Investment Intermediates Ltd |
Not Rated | |
| Axis Capital |
Not Rated | |
| Capital Market |
Neutral | |
| Dilip Davda | Apply | |
| JM Financial Institutional Securities |
Not Rated | |
| SMC Global |
Not Rated | |
| Swastika Investmart Ltd |
Apply | |
| Ventura Securities Limited |
Apply | |
The Captial Market (CapitalMarket.com) rating for Kronox Lab Sciences IPO is 46. Their analysis recommends May subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 46 | May subscribe |
[Dilip Davda] The company is in high-purity speciality chemical segment and enjoys virtual monopoly in certain products. Its product portfolio currently has 185 products and another 122 is in the pipeline. Based on FY24 annualized earnings, the issue appears fully priced. Investors may park funds for the medium to long term rewards. Read detail review...
Kronox Lab Sciences Limited peer comparison with similar listed entities. (As on March 31, 2023)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Kronox Lab Sciences Limited | 4.30 | 4.30 | 12.04 | 37.19 | 11.30 | ||
| Tatva Chintan Pharma Chem Limited | 19.45 | 19.45 | 220.07 | 57.57 | 8.84 | 5.09 | Consolidated |
| Tanfac Industries Ltd. | 56.27 | 56.27 | 184.74 | 39.15 | 30.46 | 11.92 | Consolidated |
| Neogen Chemicals Ltd | 18.94 | 18.94 | 182.90 | 77.55 | 10.36 | 8.03 | Consolidated |
| Sigachi Industries Limited | 1.42 | 1.42 | 8.73 | 46.64 | 16.22 | 7.57 | Consolidated |
| DMCC Speciality Chemical Limited | 2.78 | 2.78 | 79.49 | 116.57 | 3.50 | 4.08 | Consolidated |
Source:
All the financial information for listed industry peers mentioned above is on a consolidated basis (unless otherwise available only on a standalone basis) and is sourced from the filings made with stock exchanges, available on www.bseindia.com and www.nseindia.com for the Financial Year ending March 31, 2023.
Source for Kronox Lab Sciences Limited: Based on the Restated Financial Statements for the year ended March 31, 2023. The P/E Ratio shall be computed at the Offer Price.
Notes:
Kronox Lab Sciences IPO Reviews, analysis and views by popular members. Read Kronox Lab Sciences Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 3 | 1 | 0 | 0 |
| % | 75.00 | 25.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| chIPOrgarh (200+ Posts) |
Apply for Long Term at Cut-off Price Profit-making and debt-free company.
|
| Dhanvantri |
May Apply for Listing Gain at Upper Price Band There is no pending case against company yoy making profits complete issue is offer for Sale this gives doubt against company why you are selling when you are sitting on hefty profit .No fresh issue.Company doubtful.
|
| Meeraj ipo investor |
Apply for Listing Gain at Cut-off Price Apply For Listing Gain Demand Raising continuous
|
Post Recommendation Manage Recommendations
Note:
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
